We hypothesized that treatment with melatonin alone or in combination with amitriptyline would be superior to amitriptyline alone in modifying the endogenous pain-modulating system ( PMS ) as quantified by conditional pain modulation ( CPM ) , and this change in CPM could be associated with serum brain-derived neurotrophic factor ( BDNF ) .